RBC Capital Reiterates Outperform on Privia Health Gr, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge has reiterated an Outperform rating on Privia Health Group (NASDAQ:PRVA) and maintained a price target of $28.
August 14, 2024 | 4:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Sean Dodge has reiterated an Outperform rating on Privia Health Group (NASDAQ:PRVA) and maintained a price target of $28.
The reiteration of an Outperform rating and a maintained price target of $28 by RBC Capital is a positive signal for investors, likely boosting short-term confidence and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100